Influenza A Virus Hemagglutinin / HA Antibody, Rabbit MAb

RRID Number: AB_1960331
EliteRmab®, manufactured by recombinant technology

Influenza A Virus Hemagglutinin / HA Antibody, Rabbit MAb General Information

Product name
Influenza A Virus Hemagglutinin / HA Antibody, Rabbit MAb
Validated applications
Application notes
IHC, FCM, IF, IP et al. applications haven't been validated. (Antibody's applications haven't been validated with corresponding virus positive samples. Optimal concentrations/dilutions should be determined by the end user.)
Influenza Hemagglutinin/HA
Has cross-reactivity in ELISA and WB with
H1N1 (A/Brisbane/02/2018) HA
H1N1 (A/California/04/2009) HA
H1N1 (A/California/07/2009) HA
H1N1 (A/Guangdong-Maonan/SWL1536/2019) / (A/Hawaii/70/2019) HA
H1N1 (A/Michigan/45/2015) HA
H1N1 (A/Puerto Rico/8/1934) HA
H1N1 (A/Wisconsin/588/2019) / (A/Victoria/2570/2019) HA
H3N2 (A/Brisbane/10/2007) HA
H3N2 (A/Cambodia/e0826360/2020) HA
H3N2 (A/Hong Kong/2671/2019) HA
H3N2 (A/Hong Kong/45/2019) HA
H3N2 (A/Hong Kong/4801/2014) HA
H3N2 (A/Kansas/14/2017) HA
H3N2 (A/Singapore/INFIMH-16-0019/2016) HA
H3N2 (A/Switzerland/9715293/2013) HA

Has cross-reactivity in ELISA with
H1N1 (A/Beijing/22808/2009) HA
H1N1 (A/Brevig Mission/1/1918) HA
H1N1 (A/Brisbane/59/2007) HA
H1N1 (A/England/195/2009) HA
H1N1 (A/New Caledonia/20/1999) HA
H1N1 (A/New York/18/2009) HA
H1N1 (A/Ohio/07/2009) HA
H1N1 (A/Ohio/UR06-0091/2007) HA
H1N1 (A/Solomon Islands/3/2006) HA
H1N1 (A/Texas/05/2009) HA
H1N1 (A/WSN/1933) HA
H1N2 (A/swine/Guangxi/13/2006) HA
H1N3 (A/duck/NZL/160/1976) HA
H2N2 (A/Canada/720/2005) HA
H2N2 (A/Japan/305/1957) HA
H3N2 (A/Aichi/2/1968) HA
H3N2 (A/Perth/16/2009) HA
H3N2 (A/Wisconsin/67/X-161/2005) HA
H3N2 (A/Wyoming/03/2003) HA
H4N4 (A/mallard duck/Alberta/299/1977) HA
H4N6 (A/mallard/Ohio/657/2002) HA
H4N6 (A/Swine/Ontario/01911-1/99) HA
H4N8 (A/chicken/Alabama/1/1975) HA
H5N1 (A/Anhui/1/2005) HA
H5N1 (A/Anhui/1/2005) HA2 Sub-unit
H5N1 (A/bar-headed goose/Qinghai/14/2008) HA
H5N1 (A/barnswallow/HongKong/D10-1161/2010) HA1 Subunit
H5N1 (A/Cambodia/R0405050/2007) HA
H5N1 (A/Cambodia/S1211394/2008) HA
H5N1 (A/chicken/India/NIV33487/2006) HA
H5N1 (A/Common magpie/Hong Kong/2256/2006) HA
H5N1 (A/duck/Hunan/795/2002) HA
H5N1 (A/Egypt/2321-NAMRU3/2007) HA
H5N1 (A/Egypt/N05056/2009) HA
H5N1 (A/goose/Guiyang/337/2006) HA
H5N1 (A/Hong kong/213/03) HA
H5N1 (A/Hong Kong/483/97) HA
H5N1 (A/Hubei/2011) HA
H5N1 (A/Indonesia/5/2005) HA
H5N1 (A/Japanese white-eye/Hong Kong/1038/2006) HA
H5N1 (A/turkey/Turkey/1/2005) HA
H5N1 (A/Viet Nam/1203/2004) HA
H5N1 (A/Vietnam/1194/2004) HA
H5N1 (A/whooper swan/Mongolia/244/2005) HA
H5N1 (A/Xinjiang/1/2006) HA
H5N2 (A/American green-winged teal/California/HKWF609/07) HA
H5N3 (A/duck/Hokkaido/167/2007) HA
H5N8 (A/duck/NY/191255-59/2002) HA
H6N1 (A/northern shoveler/California/HKWF115/2007) HA
H6N4 (A/chicken/HongKong/17/77) HA
H7N7 (A/chicken/Netherlands/1/03) HA
H7N7 (A/Netherlands/219/03) HA
H7N8 (A/mallard/Netherlands/33/2006) HA
H7N9 (A/Anhui/1/2013) HA
H7N9 (A/Hangzhou/1/2013) HA
H7N9 (A/Hangzhou/3/2013) HA
H7N9 (A/Pigeon/Shanghai/S1069/2013) HA
H7N9 (A/Shanghai/1/2013) HA
H7N9 (A/Shanghai/2/2013) HA
H7N9 (A/Shanghai/4664T/2013) HA
H7N9 (A/Zhejiang/1/2013) HA
H8N4 (A/pintail duck/Alberta/114/1979) HA
H9N2 (A/Chicken/Hong Kong/G9/97) HA
H9N2 (A/Guinea fowl/Hong Kong/WF10/99) HA
H9N2 (A/Hong Kong/1073/99) HA
H9N2 (A/Hong Kong/35820/2009) HA
H10N3 (A/duck/Hong Kong/786/1979) HA
H10N3 (A/mallard/Minnesota/Sg-00194/2007) HA
H10N9 (A/duck/HongKong/562/1979) HA
H11N2 (A/duck/Yangzhou/906/2002) HA
H11N9 (A/mallard/Alberta/294/1977) HA
H12N1 (A/mallard duck/Alberta/342/1983) HA
H12N5 (A/green-winged teal/ALB/199/1991) HA
H13N8 (A/black-headed gull/Netherlands/1/00) HA
H15N8 (A/duck/AUS/341/1983) HA
H16N3 (A/black-headed gull/Sweden/5/99) HA
No cross-reactivity in ELISA and WB with
Influenza B (B/Brisbane/60/2008) HA
Influenza B (B/Colorado/06/2017) HA
Influenza B (B/Florida/4/2006) HA
Influenza B (B/PHUKET/3073/2013) HA
Influenza B (B/Washington/02/2019) HA

No cross-reactivity in ELISA with
H1N1 (A/Brevig Mission/1/1918) HA
H1N1 (A/California/04/2009) HA1 Sub-unit,
Recombinant H1N1 HA protein
This antibody was obtained from a rabbit immunized with purified, recombinant Influenza A virus H1N1 Hemagglutinin extracellular domain.
Monoclonal Rabbit IgG Clone #2
Protein A
0.2 μm filtered solution in PBS
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

Influenza A Virus Hemagglutinin / HA Antibody, Rabbit MAb Validated Applications

Application Dilution
WB 1:5000-1:20000
ELISA 1:1000-1:2000
Please Note: Optimal concentrations/dilutions should be determined by the end user.

Influenza A Virus Hemagglutinin / HA Antibody, Rabbit MAb Images

Anti-HA rabbit monoclonal antibody at 1:5000 dilution.

Sample: Reocombinant Protein 10 ng

Lane 1: H1N1 (A/Brisbane/02/2018) HA (Cat#40719-V08H)

Lane 2: H1N1 (A/California/04/2009) HA (Cat#11055-V08H)

Lane 3: H1N1 (A/California/07/2009) HA(Cat#11085-V08B)

Lane 4: H1N1 (A/Guangdong-Maonan/SWL1536/2019) HA (Cat#40717-V08H)

Lane 5: H1N1 (A/Michigan/45/2015) HA (Cat#40567-V08H1)

Lane 6: H1N1 (A/Puerto Rico/8/1934) HA (Cat#11684-V08H)

Lane 7: H1N1 (A/Wisconsin/588/2019) / (A/Victoria/2570/2019) HA (Cat#40787-V08H)

Lane 8:H3N2 (A/Brisbane/10/2007) HA (Cat#11056-V08H)

Lane 9: H3N2 (A/Cambodia/e0826360/2020) HA (Cat#40789-V08H)

Lane 10: H3N2 (A/Hong Kong/2671/2019) HA (Cat#40721-V08H)

Lane 11: H3N2 (A/Hong Kong/45/2019) HA (Cat#40765-V08H)

Lane 12: H3N2 (A/Hong Kong/4801/2014) HA (Cat#40555-V08B)

Lane 13: H3N2 (A/Kansas/14/2017) HA (Cat#40720-V08H)

Lane 14: H3N2 (A/Singapore/INFIMH-16-0019/2016) HA (Cat#40580-V08H)

Lane 15: H3N2 (A/Switzerland/9715293/2013) HA (Cat#40497-V08B)

Lane 16: Influenza B (B/Brisbane/60/2008) HA (Cat#40016-V08B)

Lane 17: Influenza B (B/Colorado/06/2017) HA (Cat#40581-V08H)

Lane 18: Influenza B (B/Florida/4/2006) HA (Cat#11053-V08H)

Lane 19: Influenza B (B/PHUKET/3073/2013) HA (Cat#40498-V08B)

Lane 20: Influenza B (B/Washington/02/2019) HA (Cat#40722-V08H)


Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution

Developed using the ECL technique.

Performed under reducing conditions.

Hemagglutinin/HA Background Information

The influenza viral Hemagglutinin (HA) protein is a homotrimer with a receptor binding pocket on the globular head of each monomer.HA has at least 18 different antigens. These subtypes are named H1 through H18.HA has two functions. Firstly, it allows the recognition of target vertebrate cells, accomplished through the binding to these cells' sialic acid-containing receptors. Secondly, once bound it facilitates the entry of the viral genome into the target cells by causing the fusion of the host endosomal membrane with the viral membrane. The influenza virus Hemagglutinin (HA) protein is translated in cells as a single protein, HA, or hemagglutinin precursor protein. For viral activation, hemagglutinin precursor protein (HA) must be cleaved by a trypsin-like serine endoprotease at a specific site, normally coded for by a single basic amino acid (usually arginine) between the HA1 and HA2 domains of the protein. After cleavage, the two disulfide-bonded protein domains produce the mature form of the protein subunits as a prerequisite for the conformational change necessary for fusion and hence viral infectivity.
Full Name
Harvey rat sarcoma viral oncogene homolog
  • White JM, Hoffman LR, Arevalo JH, et al. Attachment and entry of influenza virus into host cells. Pivotal roles of hemagglutinin. In Chiu W, Burnett RM, Garcea RL. Structural Biology of Viruses.1997
  • Suzuki Y.Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol. Pharm. Bull. 2005.
  • Senne DA, Panigrahy B, Kawaoka Y, et al. Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. Avian Dis. 1996
  • Donald J. Benton,Influenza hemagglutinin membrane anchor,PNAS,2018
  • Influenza A virus Utilizes a Suboptimal Kozak Sequence to Fine-tune Virus Replication and Host Response
    Wang, J;Peng, Y;Zhao, L;Cao, M;Hung, T;Deng, T;
    J. Gen. Virol.
  • New insights into the non-conserved non-coding region of the subtype-determinant HA and NA segments of influenza A viruses
    Zhao, L;Peng, Y;Zhou, K;Cao, M;Wang, J;Wang, X;Jiang, T;Deng, T;
    J. Virol.
  • Synthesis and anti-influenza virus activity of 4-oxo- or thioxo-4,5-dihydrofuro[3,4-c]pyridin-3(1H)-ones
    Jang, YJ;Achary, R;Lee, HW;Lee, HJ;Lee, CK;Han, SB;Jung, YS;Kang, NS;Kim, P;Kim, M;
    Antiviral Res.
  • Protective neutralizing influenza antibody response in the absence of T follicular helper cells
    Miyauchi, K;Sugimoto-Ishige, A;Harada, Y;Adachi, Y;Usami, Y;Kaji, T;Inoue, K;Hasegawa, H;Watanabe, T;Hijikata, A;Fukuyama, S;Maemura, T;Okada-Hatakeyama, M;Ohara, O;Kawaoka, Y;Takahashi, Y;Takemori, T;Kubo, M;
    Nat. Immunol.
  • The dual roles of the HA segment-specific noncoding nucleotides in the extended duplex region of the influenza A virus RNA promoter
    Wang, J;Li, J;Zhao, L;Cao, M;Deng, T;
    J. Virol.
  • In Vitro and In Vivo Antiviral Activity of Nylidrin by Targeting the Hemagglutinin 2-Mediated Membrane Fusion of Influenza A Virus
    Jang, Y;Shin, JS;Lee, JY;Shin, H;Kim, SJ;Kim, M;

Standard Antibody Development Service

Rabbit MAb

Mouse MAb

Rabbit PAb

Fast Antibody Development Service

Mouse MAb

Rabbit PAb

Add to Cart Successfully Add to Cart Failed Shopping cart is being updated, please wait U.S.A.